CCA CATO Associate Clinical Trial Operations 2

Question 1

Which document outlines the rights, safety, and well-being protections for clinical trial participants and must be reviewed by an IRB/IEC before a trial begins?

Accepted Answer

Informed Consent Form

Answer

The Informed Consent Form (ICF) must be reviewed and approved by the IRB/IEC prior to trial initiation to protect participant rights.

Question 2

In a randomized controlled trial, what is the primary purpose of blinding?

Accepted Answer

To eliminate bias in treatment assignment and outcome assessment

Answer

Blinding prevents knowledge of treatment assignment from influencing outcome assessment, reducing bias in the trial results.

Question 3

What term describes the process by which a sponsor transfers some or all trial-related duties to a Contract Research Organization (CRO)?

Accepted Answer

Outsourcing

Answer

Outsourcing refers to the formal transfer of trial-related tasks and functions from a sponsor to a CRO.

Question 4

Which phase of clinical development is primarily designed to establish the maximum tolerated dose (MTD) of a new drug?

Accepted Answer

Phase I

Answer

Phase I trials are first-in-human studies focused on safety, tolerability, and identifying the maximum tolerated dose.

Question 5

A protocol deviation that significantly affects the rights, safety, or well-being of participants is classified as a:

Accepted Answer

Serious breach

Answer

A serious breach is a deviation that significantly impacts participant safety, rights, or data integrity and requires regulatory notification.

(CCA) CATO Certified Associate Practice Test

(CCA) CATO Certified Associate Practice Test

CCA CATO Associate Clinical Trial Operations 2